These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1343 related items for PubMed ID: 12743773

  • 21. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT, Steen KS, Lems WF, Bijlsma JW, van de Laar MA, Huisman AM, Vonkeman HE, Houben HH, Kadir SW, Kostense PJ, van Tulder MW, Kuipers EJ, Boers M, Dijkmans BA.
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [Abstract] [Full Text] [Related]

  • 22. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N, Park SH, Seo GS, Lee SW, Kim JW, Lee KJ, Shin WC, Kim TN, Park MI, Park JJ, Hong SJ, Shim KN, Kim SW, Shin YW, Chang YW, Chun HJ, Lee OJ, Jeon WJ, Park CG, Cho CM, Park CH, Won SY, Lee GH, Park KS, Shin JE, Kim HU, Park JY, Chae HS, Song GA, Kim JG, Yoon BC, Seol S, Jung HC, Chung IS.
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [Abstract] [Full Text] [Related]

  • 23. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004 Dec; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 24. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Mak SK, Loo CK, Wong PN, Lo KY, Tong GM, Lam EK, Wong AK.
    Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780
    [Abstract] [Full Text] [Related]

  • 25. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD.
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [Abstract] [Full Text] [Related]

  • 26. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
    Isakov VA, Maev IV, Simanenkov VI, Kononov AV, Abdulkhakov RA, Zakharova NV, Livzan MA, Predvechnaia IK.
    Ter Arkh; 2003 Jul; 75(11):71-3. PubMed ID: 14708448
    [Abstract] [Full Text] [Related]

  • 27. Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients.
    Deltenre M, Jonas C, van Gossum M, Buset M, Otero J, De Koster E.
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S39-44. PubMed ID: 8574734
    [Abstract] [Full Text] [Related]

  • 28. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
    Lüth S, Teyssen S, Kölbel CB, Singer MV.
    Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
    [Abstract] [Full Text] [Related]

  • 29. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP, Boixeda D, Aller R, de la Serna C, Sanz E, Martín de Argila C, Abraira V, García Plaza A.
    Med Clin (Barc); 1999 Feb 13; 112(5):161-5. PubMed ID: 10091208
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
    Assem M, El Azab G, Rasheed MA, Abdelfatah M, Shastery M.
    Eur J Intern Med; 2010 Aug 13; 21(4):310-4. PubMed ID: 20603042
    [Abstract] [Full Text] [Related]

  • 31. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
    García-Romero E, del Val A, Garrigues V, Cuquerella J, Higón MD, Barrachina M, Pons V, Bixquert M, Ponce J.
    Gastroenterol Hepatol; 1999 Jan 13; 22(1):1-6. PubMed ID: 10089703
    [Abstract] [Full Text] [Related]

  • 32. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U, Raps S, Plein K, Leodolter A, Hotz Dagger J, Malfertheiner P.
    Dtsch Med Wochenschr; 2004 Mar 26; 129(13):671-5. PubMed ID: 15026962
    [Abstract] [Full Text] [Related]

  • 33. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
    Hsu CC, Lu SN, Changchien CS.
    Hepatogastroenterology; 2003 Mar 26; 50(53):1731-4. PubMed ID: 14571829
    [Abstract] [Full Text] [Related]

  • 34. Failure of Helicobacter pylori eradication: is poor compliance the main cause?
    Wermeille J, Cunningham M, Dederding JP, Girard L, Baumann R, Zelger G, Buri P, Metry JM, Sitavanc R, Gallaz L, Merki H, Godin N.
    Gastroenterol Clin Biol; 2002 Mar 26; 26(3):216-9. PubMed ID: 11981460
    [Abstract] [Full Text] [Related]

  • 35. [Erradicating treatment of Helicobacter pylori with lansoprazole and amoxicillin in duodenal ulcer patients].
    Gisbert JP, Boixeda D, Alvarez Baleriola I, Martín de Argila C, Bermejo F, Aller R.
    Rev Clin Esp; 1996 Sep 26; 196(9):588-93. PubMed ID: 8966319
    [Abstract] [Full Text] [Related]

  • 36. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
    Fujioka T, Uribe RU, Kubota T, Murakami K, Kawasaki H, Nasu M.
    Eur J Gastroenterol Hepatol; 1995 Aug 26; 7 Suppl 1():S35-8. PubMed ID: 8574733
    [Abstract] [Full Text] [Related]

  • 37. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
    Chaudhary A, Ahuja V, Bal CS, Das B, Pandey RM, Sharma MP.
    Helicobacter; 2004 Apr 26; 9(2):124-9. PubMed ID: 15068413
    [Abstract] [Full Text] [Related]

  • 38. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication.
    Chuang CH, Sheu BS, Kao AW, Cheng HC, Huang AH, Yang HB, Wu JJ.
    Hepatogastroenterology; 2007 Apr 26; 54(73):320-4. PubMed ID: 17419283
    [Abstract] [Full Text] [Related]

  • 39. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F, Gonvers JJ, Wietlisbach V, Burnand B, Hildebrand P, Schneider C, Saraga E, Beglinger C, Vader JP, Eradication in Dyspepsia (ERADYS) Study Group.
    Am J Gastroenterol; 2001 Aug 26; 96(8):2329-36. PubMed ID: 11513170
    [Abstract] [Full Text] [Related]

  • 40. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J, Börsch G.
    Am J Gastroenterol; 1994 Oct 26; 89(10):1785-8. PubMed ID: 7942667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 68.